Remove 2025 Remove HIPAA Remove Labelling
article thumbnail

Pharmaceutical Marketing in 2025: Trends, Tech, and Targeting That Matter Most

Pharma Marketing Network

Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. As automation becomes smarter, ensuring HIPAA and GDPR compliance remains critical. However, marketers must balance innovation with privacy.

HIPAA 52
article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3. Global Strategy on Digital Health 2020-2025.” 2022.2040.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

There are important considerations if the DHTT is classified as a medical device, which may change the level of regulatory controls and evidentiary requirements to support its appropriate use, such as off-label versus on-label use of a device with prior marketing authorization. Global Strategy on Digital Health 2020-2025.”

article thumbnail

Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution

The FDA Law Blog

Were not trying to bury the lead here, but the battle of labeling these surgical and drug treatments is a political one. The political battle went into gear on January 28, 2025, with an Executive Order titled Protecting Children from Chemical and Surgical Mutilation. See United States v. Facteau , 89 F.4th 4th 1, 22-26 (1st Cir.